Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Neurology(R) Neuroimmunology & Neuroinflammation|October 8, 2025
CSF Beta-Synuclein, SNAP-25, and Neurogranin in Infectious and Autoimmune Inflammatory Neurologic DiseasesSamir Abu-Rumeileh, Deborah K Erhart, Lorenzo Barba, et al.Neurology(R) Neuroimmunology & Neuroinflammation|September 25, 2020
Serum neurofilament light chain: No clear relation to cognition and neuropsychiatric symptoms in stable MSOrhan Aktas, Alina Renner, André Huss, et al.Annals of Clinical and Translational Neurology|December 19, 2023
Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.Therapeutic Advances in Neurological Disorders|March 30, 2023
Retrospective cohort study to devise a treatment decision score predicting adverse 24-month radiological activity in early multiple sclerosisAlexander Hapfelmeier, Begum Irmak On, Mark Mühlau, et al.Journal of Neurology|April 6, 2023
Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosisSven Jarius, Orhan Aktas, Ilya Ayzenberg, et al.Journal of Neurology|September 7, 2023
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term managementTania Kümpfel, Katrin Giglhuber, Orhan Aktas, et al.Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.Multiple Sclerosis and Related Disorders|November 24, 2023
Patient-reported outcome parameters and disability worsening in progressive multiple sclerosisAhmed Abdelhak, Kai Antweiler, Markus C Kowarik, et al.European Journal of Neurology|February 4, 2026
Age, Low Immunoglobulin G, and M Serum Levels Predict Infections in People With AQP4-IgG+ NMOSD Treated With Rituximab-A Multicenter Cohort Study From the German Neuromyelitis Optica Study Group (NEMOS)Daniel Engels, Mariella Herfurth, Joachim Havla, et al.Neurological Research and Practice|May 5, 2026
Socioeconomic impact of depression and pain in patients with neuromyelitis optica spectrum disordersDaria Tkachenko, Ilya Ayzenberg, Louisa M Schöppe, et al.Pageof 7